Skip to main content
. 2019 Mar 26;24(9):1270–1284. doi: 10.1634/theoncologist.2018-0112

Figure 3.

image

Therapies for patients with NSCLC ineligible for targeted therapy or immunotherapy. Note that NCCN recommends many regimens for metastatic nonsquamous or squamous NSCLC; this is an incomplete list. Some of these agents are not recommended by NCCN.

Abbreviation: NSCLC, non‐small cell lung cancer.